C21 Investments Crecimiento futuro

Future controles de criterios 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for C21 Investments.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	54.4%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Some Confidence Is Lacking In C21 Investments Inc. (CSE:CXXI) As Shares Slide 27%

Mar 09

Is C21 Investments (CSE:CXXI) A Risky Investment?

Sep 04

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

Mar 21

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

Nov 29

C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Oct 12

A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Apr 22

Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?

Mar 22

C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations

Oct 05

We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt

Sep 03

C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly

Mar 07

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como C21 Investments no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

CNSX:CXXI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	27	0	5	5	N/A
1/31/2024	28	-3	3	3	N/A
10/31/2023	29	-3	3	4	N/A
7/31/2023	29	-2	5	6	N/A
4/30/2023	29	0	6	6	N/A
1/31/2023	29	1	5	6	N/A
10/31/2022	30	3	6	7	N/A
7/31/2022	30	6	6	7	N/A
4/30/2022	32	8	5	6	N/A
1/31/2022	33	12	4	7	N/A
10/31/2021	32	8	3	6	N/A
7/31/2021	33	8	5	8	N/A
4/30/2021	34	2	8	10	N/A
1/31/2021	33	-5	8	9	N/A
10/31/2020	36	-22	10	10	N/A
7/31/2020	38	-29	9	9	N/A
4/30/2020	38	-31	8	8	N/A
1/31/2020	38	-33	5	6	N/A
10/31/2019	30	-23	-2	-1	N/A
7/31/2019	20	-21	-7	-6	N/A
4/30/2019	10	-26	-12	-11	N/A
1/31/2019	3	-24	-12	-11	N/A
10/31/2018	0	-12	-7	-7	N/A
7/31/2018	0	-9	-5	-5	N/A
4/30/2018	N/A	-2	-1	-1	N/A
1/31/2018	N/A	-1	N/A	-1	N/A
10/31/2017	N/A	0	N/A	0	N/A
7/31/2017	N/A	0	N/A	0	N/A
4/30/2017	N/A	0	N/A	0	N/A
1/31/2017	N/A	0	N/A	0	N/A
10/31/2016	N/A	0	N/A	0	N/A
7/31/2016	N/A	0	N/A	0	N/A
4/30/2016	N/A	0	N/A	0	N/A
1/31/2016	N/A	0	N/A	0	N/A
10/31/2015	N/A	0	N/A	0	N/A
7/31/2015	N/A	0	N/A	0	N/A
4/30/2015	N/A	0	N/A	0	N/A
1/31/2015	N/A	0	N/A	0	N/A
10/31/2014	N/A	0	N/A	0	N/A
7/31/2014	N/A	0	N/A	0	N/A
4/30/2014	N/A	0	N/A	0	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Insufficient data to determine if CXXI's forecast earnings growth is above the savings rate (2.2%).

Beneficios vs. Mercado: Insufficient data to determine if CXXI's earnings are forecast to grow faster than the Canadian market

Beneficios de alto crecimiento: Insufficient data to determine if CXXI's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: Insufficient data to determine if CXXI's revenue is forecast to grow faster than the Canadian market.

Ingresos de alto crecimiento: Insufficient data to determine if CXXI's revenue is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Insufficient data to determine if CXXI's Return on Equity is forecast to be high in 3 years time

C21 Investments Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

C21 Investments Inc. to Report Q2, 2025 Results on Nov 15, 2024

C21 Investments Inc., Annual General Meeting, Dec 06, 2024

Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price

Insufficient new directors

C21 Investments Inc. announced delayed 20-F filing

C21 Investments Inc.'s (CSE:CXXI) 30% Share Price Surge Not Quite Adding Up

Full year 2024 earnings released: US$0.021 loss per share (vs US$0.012 profit in FY 2023)

C21 Investments Inc. announced that it has received CAD 4 million in funding

A Look At The Intrinsic Value Of C21 Investments Inc. (CSE:CXXI)

Now 29% undervalued

New major risk - Share price stability

Now 21% undervalued

C21 Investments Inc. announced that it expects to receive CAD 4 million in funding

Some Confidence Is Lacking In C21 Investments Inc. (CSE:CXXI) As Shares Slide 27%

Now 21% undervalued

C21 Investments Inc., Annual General Meeting, Apr 26, 2024

Now 20% undervalued

Now 22% undervalued

Third quarter 2024 earnings released: US$0.003 loss per share (vs US$0.002 profit in 3Q 2023)

Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.013 profit in 2Q 2023)

C21 Investments Inc. Announces Appointment of Aron Swan as Chief Operating Officer

Is C21 Investments (CSE:CXXI) A Risky Investment?

Less than half of directors are independent

C21 Investments Inc. announced delayed 20-F filing

C21 Investments Inc., Annual General Meeting, Jul 27, 2023

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

Third quarter 2023 earnings released: EPS: US$0.002 (vs US$0.028 in 3Q 2022)

C21 Investments Inc. to Report Q3, 2022 Results on Dec 15, 2022

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Second quarter 2023 earnings released: EPS: US$0.013 (vs US$0.031 in 2Q 2022)

C21 Investments Inc. announced delayed 20-F filing

C21 Investments Inc., Annual General Meeting, Jul 28, 2022

A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations

We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt

First quarter 2022 earnings released: EPS US$0.037 (vs US$0.019 loss in 1Q 2021)

Full year 2021 earnings released: US$0.058 loss per share (vs US$0.42 loss in FY 2020)

C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly

C21 Investments Inc. Announces Board Changes

An unknown buyer signed a definitive agreement to acquire non-core assets Of C21 Investments Inc. for $1.3 million.

C21 Investments Inc. to Report Q3, 2021 Results on Dec 16, 2020

C21 Investments Inc. (CNSX:CXXI) completed the acquisition of Swell Companies Ltd for $6.9 million.

C21 Investments Inc. Auditor Raises 'Going Concern' Doubt

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento